COVID-19: Potential sepsis treatment moves to human trials in London, Ont.
sepsis more than two decades in the making is another step closer to reality, with the launch of a clinical trial involving COVID-19 patients in London, Ont.Lawson Health Research Institute says enrolment for the clinical trial is already underway, with a goal of including 60 critically ill COVID-19 patients.If the trial results show promise, Lawson scientist Dr.
Qingping Feng’s team plans to expand to a larger phase III trial involving “not just COVID-19 patients with sepsis, but other sepsis patients as well.” Potential sepsis treatment could be ready in 5 years thanks to London, Ont., researcher Sepsis is a potentially fatal condition wherein the body overreacts to an infection, leading to an overwhelming inflammatory response that can.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|